FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019701 [Registered on: 17/06/2019] Trial Registered Prospectively
Last Modified On: 12/06/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Check the Usefulness of Local Anesthetic injection into the Erector Spinae muscle (ERECTOR SPINAE BLOCK) in Patients operated for Breast Cancer. 
Scientific Title of Study   EFFICACY OF ERECTOR SPINAE BLOCK IN BREAST SURGERY PATIENTS- An Interventional, Prospective, Randomised control study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
3277 Version 1.1 dated 08.05.2019  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr J V Divatia 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Dept. of Anaesthesia, Critical Care and Pain, Second Floor, Main Building, Tata Memorial Hospital Parel, Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  9869077435  
Fax    
Email  jdivatia@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr J V Divatia 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Dept. of Anaesthesia, Critical Care and Pain, Second Floor, Main Building, Tata Memorial Hospital Parel, Mumbai


MAHARASHTRA
400012
India 
Phone  9869077435  
Fax    
Email  jdivatia@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Prathiba Thiagarajan 
Designation  Post Graduate Student 
Affiliation  Tata Memorial Hospital 
Address  Dept. of Anaesthesia, Critical Care and Pain, Second Floor, Main Building, Tata Memorial Hospital Parel, Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  9500488833  
Fax    
Email  drprathi26@gmail.com  
 
Source of Monetary or Material Support  
Dept. of Anaesthesia, Critical Care and Pain, 2nd Floor Main Building, Tata Memorial Hospital, Dr Ernest Borges Road, Parel, Mumbai, Maharashtra 400012 
 
Primary Sponsor  
Name  Dr J V Divatia 
Address  Dept. of Anaesthesia, Critical Care and Pain, Second Floor, Main Building, Tata Memorial Hospital Parel, Mumbai 
Type of Sponsor  Other [Self Funded] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr J V Divatia  Tata Memorial Centre  Dept. of Anaesthesia, Critical Care and Pain, Second Floor, Main Building, Tata Memorial Hospital Parel, Mumbai
Mumbai
MAHARASHTRA 
9869077435

jdivatia@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC II  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C50||Malignant neoplasm of breast,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Erector Spinae Block  Patients will be placed in lateral decubitus position after induction, USG guided, probe in parasagittal plane, up to 3cm lateral to midline of at level of 5th thoracic vertebra, using in-plane technique, Erector spinae muscle is identified, and drug is deposited below the muscle using a 20G,10cm Stimuplex needle and 20ml of 0.25% Bupivacaine will be injected into the plane.  
Comparator Agent  Routine Anaesthesia Care  hese patients will undergo Breast surgery under General Anaesthesia. In induction room, Under All standard anaesthesia monitoring, Induction of anaesthesia will be done by Propofol 1-2mg/kg, fentanyl 2mcg/kg and Muscle relaxant Atracurium 0.4-0.5mg/kg or Vecuronium 0.1mg/kg. An appropriate size Supraglottic device/ETT will be placed. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  Female patients age of 18-65years, belonging to ASA I and II categories, undergoing Unilateral Modified Radical Mastectomy + Axillary Clearance/dissection 
 
ExclusionCriteria 
Details  Patients belonging to ASA III OR IV category
Patients aged <18 or >65years
Asthmatics ( As NSAID’S has to be avoided in them )
Patient refusal
B/L Breast Surgeries/ MRM+ Port insertion/BCT +BSO/Reconstructive surgeries
Infection at injection site
Spinal deformities
Coagulation disorders
Allergy to local anaesthetics
History of opioid usage for Chronic pain
Cognitive, psychiatric disorders 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Time to first analgesic requirement (Time between admission in PACU to request for first rescue pain medication)
 
24 hours post surgery or at discharge 
 
Secondary Outcome  
Outcome  TimePoints 
1. Total intraoperative opioid consumption
2. Post-operative pain scores
3. To assess Incidence of PONV
4. Patient satisfaction scores at discharge 
24 hours post surgery or at discharge 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/06/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   BACK GROUND AND INTRODUCTION: 

Breast cancer has been ranked number one cancer in Indian females. Surgery being the main stay of treatment, General anaesthesia is conventionally used for most breast surgeries. Opioids and NSAID’S are commonly used for analgesia. In female population undergoing breast cancer surgery it has been estimated that the incidence of chronic postoperative pain ranges from 25% to 50%. Among main factors responsible for it being the higher acute postoperative pain, its intensity and analgesic consumption in the acute postoperative period. One important side effect of opioids usage is PONV. Postoperative nausea and vomiting (PONV) continue to be one of the most common and disturbing complications patients experience after surgery, with an incidence as high as 80%. PONV has significant morbidity (dehydration, wound dehiscence, pain, immobility), delayed discharge, increased hospital costs, and poor patient satisfaction. 
Regional anaesthesia is widely preferred these days as they decrease the opioid requirements, thereby reducing their side effects as well. It also provides a good mode of analgesia. Regional anaesthesia commenced before surgical incision reduces incidence of chronic postsurgical pain and Post Mastectomy Pain Syndrome prevalence.THE ERECTOR SPINAE BLOCK (ESB) is an interfascial plane block. It produces extensive multidermatomal sensory blockade with its likely site of action at the dorsal and ventral rami of the thoracic spinal nerves. Local anesthetic deposited deep to erector spinae muscle which extends along the length of thoracolumbar spine, this plane permits extensive cranio-caudal spread and coverage of multiple dermatomes. It’s a promising technique for thoracic analgesia in chronic neuropathic as well as acute post-surgical and post traumatic pain.  Even though many Regional techniques for breast surgeries has shown many benefits over General anesthesia alone, the significant advantage of the ESP Block being its simplicity and safety, not time consuming and considered a better alternative to other techniques in breast cancer surgeries. The sonoanatomy is easily recognizable, and there are no structures at risk of needle injury in the immediate vicinity. Recently published Case reports of Erector spinae block being used as a regional technique in breast surgeries have shown better post op outcome and analgesia, opioid sparing effect, possible immunomodulatory effect and better patient satisfaction. However, except for these case reports on ESB for Breast surgeries, no RCT has been conducted so far, to prove the efficacy of ESB in breast surgeries over General Anesthesia alone and if it can be routinely preferred as a regional technique in breast surgeries.

AIMS AND OBJECTIVES: 

The OBJECTIVE of the study is to find the efficacy of ESB in controlling pain in Breast surgery patients 

PRIMARY AIM is to compare the following in patients undergoing Modified Radical Mastectomy with Axillary dissection/clearance under General Anaesthesia alone and in patients receiving Erector spinae block along with General Anaesthesia, 
1.Time to first analgesic requirement (Time between admission in PACU to request for first rescue pain medication) 

SECONDARY AIM is to compare the following between two groups: 
1. Total intraoperative opioid consumption 
2. Post-operative pain scores 
3. To assess Incidence of PONV 
4. Patient satisfaction scores at discharge

STUDY DESIGN:
Prospective, interventional, Double blinded, comparative Randomised controlled study 

MATERIALS AND METHODS: 
After approval from Institutional Review Board, Patients belonging to the inclusion criteria will be recruited in the study after obtaining a written consent. Since the study will presented as a thesis for MD (Anaesthesia) in May 2020 and will not be able to recruit all the subjects before December 2019, the data of patients recruited till 30 th November 2019 will be analysed for thesis purpose. It will be carried out at Tata Memorial Centre, Mumbai.

Sample size: 

In a Previous study done by somia et al, on Modified PECS block in breast surgeries,Time to rescue(TTR) analgesic increased by 2.30hrs, we expect that the Erector spinae block would prolong TTR by 4Hrs. In order to achieve this, we have taken SD=2, Significance level (alpha) of 0.05, power 80%, the actual sample size calculated is 25 patients in each arm, but we have taken 35 patients in each control and study arm respectively, to account for errors, protocol violations, etc, a total of 70 patients, 35 in each group will be randomised in the trial 
Randomisation would be by computer generated random numbers, and patients will be divided into two study groups 
Blinding: This is a Double blinded study. The patients are blinded as they are given the block under anaesthesia. The block will be given in induction room where OT anaesthetists will not be present. The Acute Pain service team who evaluates patient in PACU and ward are also blinded and wouldn’t know if the patient has received the block or not.

STUDY PROCEDURE: 

GROUP A: These patients will undergo Breast surgery under General Anaesthesia. In induction room, Under All standard anaesthesia monitoring, Induction of anaesthesia will be done by Propofol 1-2mg/kg, fentanyl 2mcg/kg and Muscle relaxant Atracurium 0.4-0.5mg/kg or Vecuronium 0.1mg/kg. An appropriate size Supraglottic device/ETT will be placed. 

Whereas in GROUP B: Patients will be placed in lateral decubitus position after induction, USG guided, probe in parasagittal plane, up to 3cm lateral to midline of at level of 5th thoracic vertebra, using in-plane technique, Erector spinae muscle is identified, and drug is deposited below the muscle using a 20G,10cm Stimuplex needle and 20ml of 0.25% Bupivacaine will be injected into the plane. The block will be performed by PI, CO PI and CI, under the supervision of PI/CO PI, provided the PI & CI had given at least 10 blocks under guidance of CO PI who has good expertise in giving this block. Patients are shifted to Operation room, and Maintenance will be with O2+Air+Sevoflurane+IPPV. Intra op Fentanyl bolus of 0.5mcg/kg iv will be given with 20% increase in heart rate/Blood pressure from baseline Intra-op Paracetamol 15mg/kg iv, Inj Diclofenac 1mg/kg and Inj Ondansetron 4mg, Dexamethasone 4mg will be given for Pain and PONV prevention respectively. Neuromuscular blockade will be reversed with Neostigmine+ Glycopyrrolate, SLMA/ETT removed and patient will be shifted to PACU

In PACU,
At the time of performance of block, it’s not possible to check the dermatomal spread, as patient is under Anesthesia. But in post op period, in PACU, dermatomal spread can be checked using Ice test once patient is wide awake Time to first rescue analgesic (time point measured from end of surgery to request of analgesic OR pain score >/= 4) will be noted in both group of patients. All the patients will be followed up in ward after discharge from PACU, we will monitor all the patients in PACU or ward till they receive the first rescue. Inj Fentanyl bolus iv will be given as first rescue analgesic if Pain score >/= 4 or patient requests for pain medication. (If Within 8hrs of intra-op paracetamol) Inj Paracetamol 15mg/kg will be given (If more than 8hrs from intraop paracetamol) Also, Total opioid and analgesic consumption, pain scores, and Incidence of PONV in first 24 hours/until discharge will be recorded in both group of patients Pain scores will be assessed by the Acute Pain Services, who are blinded to the study, using a Numerical rating scale(NRS) on a scale of 0-10, (0 being no pain and 10 being worst pain) and recorded on arrival to PACU, at 1 hr, 2hrs, 6hrs, 12hrs and by the end of 24hrs/ Or until discharge To assess Incidence of PONV – Nausea as yes/no and Vomiting, assessed both by binary variable(yes/no) and as continuous variable to measure the number of separate emetic events. Patient satisfaction score will be assessed in PACU by a scoring system of 1-4. 1- Not satisfied, 2- Fairly satisfied, 3- Satisfied, 4- Extremely satisfied. 
 
Close